Laurel Wealth Advisors (North Carolina)’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.5M | Sell |
|
|||||
|
2025
Q1 | $3.6K | Hold |
|
|||||
|
2024
Q4 | $5.5K | Hold |
|
|||||
|
2024
Q3 | $4.13K | Hold |
|
|||||
|
2024
Q2 | $5.55K | Hold |
|
|||||
|
2024
Q1 | $6.7K | Hold |
|
|||||
|
2023
Q4 | $7.47K | Hold |
|
|||||
|
2023
Q3 | $2.45K | Hold |
|
|||||
|
2023
Q2 | $3.48K | Hold |
|
|||||
|
2023
Q1 | $3.98K | Hold |
|
|||||
|
2022
Q4 | $15.6K | Hold |
|
|||||
|
2022
Q3 | $17K | Hold |
|
|||||
|
2022
Q2 | $16K | Hold |
|
|||||
|
2022
Q1 | $12K | Hold |
|
|||||
|
2021
Q4 | $13K | Hold |
|
|||||
|
2021
Q3 | $30K | Hold |
|
|||||
|
2021
Q2 | $53K | Hold |
|
|||||
|
2021
Q1 | $70K | Hold |
|
|||||
|
2020
Q4 | $65K | Sell |
|
|||||
|
2020
Q3 | $102K | Buy |
|
|||||
|
2020
Q2 | $12K | Hold |
|
|||||
|
2020
Q1 | $8K | Hold |
|
|||||
|
2019
Q4 | $14K | Hold |
|
|||||
|
2019
Q3 | $9K | Hold |
|
|||||
|
2019
Q2 | $11K | Hold |
|
|||||
|
2019
Q1 | $10K | Hold |
|
|||||
|
2018
Q4 | $11K | Buy |
|